Lycopodium Ltd. provided earnings guidance for the fiscal year 2013 and 2014. For the current 2012/13 financial year, the company expects the results to be in line with the previous record year when turnover was AUD 232.2 million (36% growth on 2010/2011) and NPAT was AUD 22.4 million. The current guidance is based predominantly on committed work which has flowed through from the peak of market activity in 2011/2012.

Considering both the market movements and identified opportunities, on balance, the company's board advises that it is unlikely sufficient work will be secured in the timeframe required to maintain the record revenues of 2011/12 and 2012/13 through the financial year 2013/14. The Board is of the current view that there will be a modest pull back and is anticipating a turnover of AUD 180 to AUD 200 million for the 2013/2014 financial year.